Rpb4/7 facilitates RNA polymerase II CTD dephosphorylation by Allepuz-Fuster, Paula et al.
13674–13688 Nucleic Acids Research, 2014, Vol. 42, No. 22 Published online 21 November 2014
doi: 10.1093/nar/gku1227
Rpb4/7 facilitates RNA polymerase II CTD
dephosphorylation
Paula Allepuz-Fuster1, Vero´nica Martı´nez-Ferna´ndez2, Ana I. Garrido-Godino2,
Sergio Alonso-Aguado1, Steven D. Hanes3, Francisco Navarro2 and Olga Calvo1,*
1Instituto de Biologı´a Funcional y Geno´mica, CSIC/Universidad de Salamanca, Salamanca 37007, Spain,
2Departamento de Biologı´a Experimental, Facultad de Ciencias Experimentales, Universidad de Jae´n, Jae´n 23071,
Spain and 3Department of Biochemistry and Molecular Biology, Upstate Medical University, Syracuse, NY 13210,
USA
Received July 31, 2014; Revised November 04, 2014; Accepted November 10, 2014
ABSTRACT
The Rpb4 and Rpb7 subunits of eukaryotic RNA poly-
merase II (RNAPII) participate in a variety of pro-
cesses from transcription, DNA repair, mRNA export
and decay, to translation regulation and stress re-
sponse. However, their mechanism(s) of action re-
mains unclear. Here, we show that the Rpb4/7 het-
erodimer in Saccharomyces cerevisiae plays a key
role in controlling phosphorylation of the carboxy ter-
minal domain (CTD) of the Rpb1 subunit of RNAPII.
Proper phosphorylation of the CTD is critical for
the synthesis and processing of RNAPII transcripts.
Deletion of RPB4, and mutations that disrupt the in-
tegrity of Rpb4/7 or its recruitment to the RNAPII
complex, increased phosphorylation of Ser2, Ser5,
Ser7 and Thr4 within the CTD. RPB4 interacted ge-
netically with genes encoding CTD phosphatases
(SSU72, FCP1), CTD kinases (KIN28, CTK1, SRB10)
and a prolyl isomerase that targets the CTD (ESS1).
We show that Rpb4 is important for Ssu72 and
Fcp1 phosphatases association, recruitment and/or
accessibility to the CTD, and that this correlates
strongly with Ser5P and Ser2P levels, respectively.
Our data also suggest that Fcp1 is the Thr4P phos-
phatase in yeast. Based on these and other re-
sults, we suggest a model in which Rpb4/7 helps
recruit and potentially stimulate the activity of CTD-
modifying enzymes, a role that is central to RNAPII
function.
INTRODUCTION
Eukaryotic RNA polymerase II (RNAPII) contains 12 sub-
units, Rpb1 to Rpb12, that in Saccharomyces cerevisiae
dissociates into a 10-subunit core and a Rpb4/Rpb7 het-
erodimer (1). Rpb4 and Rpb7 are conserved from yeast to
humans, and orthologs found in archaea also function in
transcription (2). Rpb7, but not Rpb4, is essential for via-
bility (3,4). Early studies suggested a role for the Rpb4/7
heterodimer in the transcriptional response to stress (3,5),
however, it is now clear that Rpb4/7 participates in a broad
range of activities under a variety of conditions (6,7)
In S. cerevisiae, the Rpb4/7 heterodimer is required for
promoter-dependent transcription in vitro, is involved in
elongation and termination (7) and is important for co-
transcriptional recruitment of factors required for 3′-end
formation of mRNA and snoRNA genes (8). The asso-
ciation of Rpb4/7 with elongating RNAPII may be tran-
sient and regulated by elongation factors (9). Rpb4/7 may
also function in mRNA quality control and translation,
where it is thought to bind co-transcriptionally to nascent
transcripts and promote nuclear export, and once in the
cytoplasm, stimulate translation initiation and subsequent
deadenylation and mRNA decay (10–12). However, it has
been argued that these cytoplasmic effects on gene expres-
sion are indirect, and occur in response to widespread de-
fects in mRNA synthesis (13). So while Rpb4/7 is impli-
cated in a number of important gene regulatory functions,
its mechanism(s) of action remains unclear.
Structure studies reveal that the Rpb4/7 heterodimer
forms a stalk-like protrusion extending from the main body
of the RNAPII complex (14). Similar structures are found
on eukaryotic RNA polymerases I and III, composed of
subunits Rpa14/43 and Rpc17/25, respectively (15), and
on archaeal RNA polymerase (subunits F/E) (2). Bacterial
RNA polymerases do not contain the analogous structure
and lack the homologous subunits. On the eukaryotic and
archaeal polymerases, the stalk-like protrusion is positioned
adjacent to the RNA exit channel, and in archaea, the F/E
complex binds RNA and is important for elongation pro-
cessivity (16). In the RNAPII complex, the Rpb4/7 het-
erodimer is also adjacent to the carboxy-terminal domain
(CTD) of largest subunit, Rpb1. The proximity of Rpb4/7
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to both the nascent RNA and the CTD suggests it might
play a role in the recruitment of factors important for RNA
biogenesis and/or CTD modification. Indeed, Rpb7 can
be cross-linked to the emerging RNA transcript in human
cells (17), and in Schizosaccharomyces pombe Rpb7 inter-
acts with Seb1, a termination factor homologous to Nrd1,
which in budding yeast binds both the nascentRNAand the
Ser5P form of the CTD (18,19). In S. pombe andDrosophila
melanogaster, in vitro binding and yeast two-hybrid as-
says, respectively, showed that Rpb4 interacts with Fcp1, a
Ser2P CTD phosphatase (20,21). Structural and biochemi-
cal studies suggested that in addition to direct recognition of
the phospho-CTD substrate, S. cerevisiae Fcp1 might also
interact with RNAPII through Rpb4/7 (22). These findings
suggest the Rpb4/7 might recruit Fcp1 to regulate CTD
modification.
The CTD of Rpb1 is unique to eukaryotes and is com-
posed of a repeated heptapeptide motif with a consensus
sequence of Tyr1-Ser2-Pro3-Thr4-Ser5-Pro6-Ser7 (23,24).
The CTD can be phosphorylated at Ser2, Ser5 and Ser7, as
well as Tyr1 and Thr4 (25–27), and in mammals, it can be
acetylated (28), glycosylated (29,30) andmethylated (31). In
addition, the prolyl bonds within the CTD can be isomer-
ized by the peptidyl prolyl cis-trans isomerase, Ess1 in yeast
(Pin1 in humans) (32–34). These modifications are dynamic
and collectively constitute a ‘CTD code’ (35), whereby the
various forms of the CTD differentially recruit co-factors
required for transcriptional efficiency and RNA processing
(36,37).
CTD phosphorylation is regulated by the action of ki-
nases and phosphatases (38). In S. cerevisiae, the CTD is
phosphorylated by the cyclin-dependent kinases (CDKs),
Srb10, Kin28, Ctk1 and Bur1 (27,39). Srb10 (mammalian
Cdk8), a Ser2/Ser5 kinase, is part of the Mediator complex
and inactivates RNAPII prior to pre-initiation complex for-
mation (40), and, together with Kin28 (a Ser5/Ser7 kinase),
facilitates transcription and formation of the scaffold com-
plex (41). Kin28 (mammalian Cdk7), part of the TFIIH ini-
tiation complex (42), phosphorylates Ser5 to promote co-
transcriptional 5′ mRNAcapping (43–45), and inmammals
also phosphorylates Ser7 during promoter-proximal paus-
ing and perhaps during termination (46–48). Ctk1, themain
Ser2 kinase in coding and 3′-end regions, is required for co-
transcriptional recruitment of the polyadenylation machin-
ery (49,50). In mammalian cells, Ser2P elongation marks
are placed by Cdk9/CyclinT (P-TEFb) (51) and Cdk12
(52). Finally, Bur1/Bur2 phosphorylates Ser2 near promot-
ers and stimulates Ser2 phosphorylation by Ctk1 to pro-
mote elongation (50,53). Bur1 seems also to place Ser7P
marks later in the transcription cycle (54).
CTD dephosphorylation is carried out by four phos-
phatases: Rtr1, Ssu72, Glc7 and Fcp1 (38,55). Rtr1 works
early in the CTD cycle and dephosphorylates Ser5P to pro-
mote the transition from Ser5P to Ser2P (56,57). Human
Rtr1, RPAP2, is recruited to snRNA genes via Ser7P (58).
Rtr1 lacks a recognizable catalytic domain and may play
a non-catalytic role in CTD dephosphorylation (59). In
yeast, Rtr1 has been proposed to be a Tyr1P phosphatase
(60). Ssu72 and Glc7 are components of the 3′-end pro-
cessing machinery; Ssu72 targets Ser5P and Ser7P for de-
phosphorylation (61–64), while Glc7 targets Tyr1P (55), a
mark important to avoid premature recruitment of termi-
nation factors within gene bodies (65). Fcp1 is essential and
is specific for Ser2P dephosphorylation in vivo and opposes
Ctk1 (50) to ensure proper levels of Ser2P during elonga-
tion (50,61,66). Fcp1 dephosphorylation of Ser2P after ter-
mination is assisted prior to the action of Ssu72 (61). Addi-
tionally, in mammals, Fcp1 has been described as the Thr4P
phosphatase (67).
The phosphorylation state of the CTD is also regulated
by the Ess1/Pin1 prolyl isomerase. In yeast, Ess1 promotes
dephosphorylation of Ser5P (and Ser7P) (34,63,68). It does
so by providing a kinetic advantage to the binding and cat-
alytic activity of Ssu72, which requires a cis-conformation
of the CTD Ser5P-Pro6 bond (69). In mammalian cells,
Pin1 promoted Ser2/Ser5 phosphorylation of the CTD via
inhibition of Fcp1 and stimulation of Cdc2 kinase (70).
How co-factors are recruited to RNAPII to facilitate
transcription and RNA processing remains poorly under-
stood. Prior work suggested a role for Rpb4/7 in recruit-
ment of co-factors important for RNA processing and/or
modification of the CTD. Here, we sought to determine
whether the Rpb4/7 heterodimer influences CTD phospho-
rylation, and if so, by what mechanism. Results of genetic
and biochemical experiments reveal that Rpb4/7 is impor-
tant to maintain proper levels of RNAPII phosphoryla-
tion, and that it functions by a mechanism(s) that involves
Rpb4/7-dependent association, recruitment and/or acces-
sibility, of key CTD modifying enzymes.
MATERIALS AND METHODS
Yeast strains, media, plasmids and oligonucleotides
The strains used are listed in Supplementary Table I. Strain
construction and other genetic manipulations were per-
formed following standard procedures (71). Plasmids and
oligonucleotide sequences used in this study are listed in
Supplementary Table II and III, respectively.
Chromatin isolation
Chromatin isolation was performed as described (72) with
modifications. Briefly, about 5 × 108 cells growing expo-
nentially (OD600 ∼ 0.6–0.8) were resuspended in 3 ml of
100 mM PIPES/KOH (pH 9.4) containing 10 mM DTT
and 0.1% sodium azide and incubated at room tempera-
ture for 10 min. After concentration by centrifugation, cells
were resuspended in 2 ml of 50 mM phosphate buffer (pH
7.5), containing 0.6 M Sorbitol, 10 mM DTT and 4 l of
20 mg/ml zymolyase and were incubated 10 min at 37◦C.
Spheroplasts were pelleted at 4◦C, washed with 50 mM
HEPES-HOK buffer (pH 7.5) containing 100 mMKCl, 2.5
mM MgCl2 and 0.4 M Sorbitol, and resuspended in equal
volume (∼80 l) of EBX buffer (50 mM HEPES/KOH,
pH 7.5), containing 100 mM KCl, 2.5 mM MgCl2, 0.25%
Triton-X100, 0.5 mM PMSF, 0.5 mM DTT and 1× pro-
tease inhibitor cocktail (Complete; Roche) and incubated
for 3 min on ice. Spheroplasts break under these condi-
tions and the resulting whole-cell extracts were added to
400 l of EBX-S buffer (EBX with 30% sucrose) and cen-
trifuged at 12 000 revolutions per minute (rpm) for 10
min. After centrifugation, a chromatin pellet which was
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visible, was washed with 400 l of EBX buffer and re-
suspended in 50 l of 1.5× Tris-Glycine SDS Sample
Buffer and incubated for 2 min at 85◦C, followed by cen-
trifugation at 10 000 rpm for 30 s. A 1:3 dilution of the
chromatin pellet was used for sodium dodecyl sulphate-
polyacrylamide gel electrophoresis (SDS-PAGE) and west-
ern analysis using anti-Histone H3 (ab1791; Abcam), anti-
phosphoglycerate kinase (459250; Invitrogen), Y-80 anti-
Rpb1 (sc-25758, Santacruz), anti-CTD-Ser5 (anti-RNA
polymerase II; CTD4H8, Millipore), anti-CTD-Ser2 (anti-
RNA polymerase II; ab5095, Abcam), anti-CTD-Ser7
(anti-RNA polymerase II; 4E12, ChromoTek), anti-Rpb4
(2Y14; Santa Cruz) or 9E10 anti-C-Myc (Santa Cruz). In-
tensities of immunoreactive bands on western blots were
quantified by densitometry of scanned images using TO-
TALLAB software. The data are the results of at least three
independent experiments.
Co-immunoprecipitation (Co-IP) and western blot analysis
Rpb3 IP was performed as follows: wild-type and rpb4
cells were grown in rich medium to an OD600 of 0.8, har-
vested, washed with water and resuspended in 250 l lysis
buffer (10 mM HEPES-KOH at pH 7.5, 140 mM NaC1,
1 mM EDTA, 10% glycerol, 0.1% NP-40, 1 mM PMSF
and 1× protease inhibitor cocktail (Complete; Roche). Cell
lysis was achieved at 4◦C using a FastPrep System. Anti-
Rpb3 antibody (WPO12, Neoclone) coupled to protein A
Sepharose was incubated for 1 h at 4◦C and after sev-
eral washes of the clarified whole cell extracts (WCE) were
added and immunoprecipitated for 3 h at 4◦C. The IPs were
extensively washed and resuspended in SDS-PAGE sample
buffer. Western blot analysis was performed using the ap-
propriate antibodies, detailed above. The enhanced chemi-
luminescence (ECL) reagents were used for detection. The
signal was acquired on film and/or with a ChemiDoc XRS
(Bio-Rad) system and quantified with the Quantity One
software (Bio-Rad). The data plotted correspond to values
means from at least three different experiments, and the er-
ror bars represent standard deviations.
Chromatin immunoprecipitation (ChIP)
Chromatin purification, IP, quantitative real-time poly-
merase chain reaction (qPCR) amplification and data anal-
ysis were performed as described (73). Briefly, PCR of pu-
rified chromatin, following IP, was performed by real-time
qPCR with and CFX96 Detection System (Bio-Rad Lab-
oratories, Inc.), using SsoAdvancedTM Universal SYBR R©
Green Supermix (Bio-Rad) following manufacturer’s in-
structions. Four serial 10-fold dilutions of genomic DNA
were amplified using the same reaction mixture as the sam-
ples to construct the standard curves. Real-time PCR reac-
tions were performed in triplicate and with at least three in-
dependent ChIPs. Quantitative analysis was carried out us-
ing the CFX96 Manager Software (version 3.1, Bio-Rad).
The values obtained for the IP’s PCR products were com-
pared to those of the total input, and the ratio of the values
from each PCR product from transcribed genes to a non-
transcribed region of CVII was calculated. Numbers on the
y-axis of graphs are detailed in the corresponding figure leg-
end.
RNA isolation and reverse transcriptase-qPCR (RT-qPCR)
Total RNA was extracted as described (74), and re-
verse transcribed using the iScript RT reagent Kit (Bio-
Rad.), following the manufacturer’s instructions. Real-time
RT-qPCR was performed using a CFX-384 Real-Time
PCR instrument (BioRad) and EvaGreen detection sys-
tem ‘SsoFastTM EvaGreen R© Supermix’ (BioRad). Reac-
tions were performed in 10 l total volume containing
cDNA corresponding to 0.1 ng of total RNA. PCR reac-
tions were performed at least three times with three inde-
pendent biological replicates. The 18S rRNA gene was used
for normalization.
RESULTS
Deletion of RPB4 or mutations impairing Rpb4/7 het-
erodimer association increase Rpb1-CTD phosphorylation
Previous work showed that levels of Ser2P CTD increase in
the absence of RPB4 (rpb4) (8) . This increase had been
attributed to an overall increase RPB1 mRNA and Rpb1
protein levels. Here, we examined the phosphorylation of
Ser2CTD inmore detail, and extended our analysis to other
phosphorylation sites, Ser5 and Ser7. In agreement with
the published work (8), we observed an increase in Ser2P
levels in rpb4 cells, as well as increased total Rpb1 pro-
tein, as detected using an antibody (Y-80) that recognizes
the N-terminus of Rpb1, independent of CTD phosphory-
lation (Figure 1A). However, we do not detect an increase
inRPB1mRNA levels in rpb4 cells (Figure 1D), although
its relative abundance may increase relative to that of other
mRNAs, which show a significant decrease (Supplementary
Figure S1 and (13). The increase in bulk CTD phosphoryla-
tion exceeded, albeit modestly, the increase in Rpb1 protein
levels, suggesting that in rpb4 cells, Ser2P levels increase
relative to that in wild-type cells (Figure 1A, right panel).
Examination of Ser5P and Ser7P levels in rpb4 mu-
tants showed similar results, a strong increase in phospho-
rylation, particularly for Ser7, that exceeded the increase in
Rpb1 levels (Figure 1A). Moreover, two different rpb7 mu-
tants (rpb7–33 (10) and rpb7-ΔC3 (a gift from P. Thuriaux))
also displayed increases in Ser2P, Ser5P and Ser7P (Fig-
ure 1B). These rpb7mutants show reduced Rpb4 levels, but
notably, the levels of Rpb1 were not increased (Figure 1B
and D). Finally, cells bearing the rpb6-Q100R mutation,
which reduces the association of the Rpb4/7 heterodimer
with RNAPII (75) also showed enhanced CTD phosphory-
lation without altering Rpb1 protein or RPB1 mRNA lev-
els (Figure 1C and D). From these data, we conclude that
proper phosphorylation of the RNAPII CTD depends on a
functional Rpb4/7 heterodimer.
We also analyzed the mRNA expression pattern of three
constitutively transcribed genes in rpb4Δ, rpb7-ΔC3 and
rpb6-Q100R mutant cells, as well as in their correspond-
ing isogenic wild-type strains, at the permissive temperature
of 28oC (Supplementary Figure S1). The rpb7-ΔC3 muta-
tion caused a significant reduction in steady-state levels of
mRNA, although not to the level of an RPB4 deletion. In
contrast, the rpb6-Q100Rmutant did not significantly affect
mRNA levels. For rpb4Δ and rpb7-ΔC3mutants, the lower
mRNA levels might be due to reduced initiation, consistent
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Figure 1. Deletion of RPB4 or mutations that reduce Rpb4/7 heterodimer association increase Rpb1-CTD phosphorylation. (A) Left panel: WCE were
prepared fromwild-type (wt) and rpb4 strains and analyzed bywestern blotting using the following antibodies: anti-Rpb1 (Y-80), anti-CTD-Ser5P (4H8),
anti-CTD-Ser2P (ab5095), anti-CTD-Ser7P (4E12) and anti-Rpb4 (2Y14). Anti-Rpb3 was used as control for RNAPII levels and anti-Pgk1 (phospho-
glycerate kinase) as a control for total protein. Right panel: Plots of Ser2P/Rpb1, Ser5P/Rpb1 and Ser7P/Rpb1 ratios determined by quantitation (by
densitometry) of immunoreactive bands on western blots. The mean values and standard deviations are from three independent experiments. (B and C)
WCE from rpb7–33, rpb7-ΔC3 and rpb6-Q100R mutants and isogenic wt controls were analyzed as in (A). (D) qRT-PCR of RPB1 mRNA levels in the
indicated strain backgrounds. The 18S rRNA gene was used as a control. (E) Western analysis of Rpb1 phosphorylation in chromatin fractions from
rpb4, rpb7-ΔC3 and rpb6-Q100Rmutant strains and their isogenic wt controls. rpb5-H147R served as control for no effect on RNAPII phosphorylation,
and histone H3 and Pgk1 were used as controls for nuclear and cytoplasmic proteins, respectively. Lower panels: Ratios calculated by quantitation of
immunoreactive bands on western blots.
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Figure 2. Rpb1-CTD Ser5P and Ser2P occupancy in rpb4Δ cells. (A) ChIP analyses was performed using wt and rpb4 strains. Rpb1 binding to the 5′
promoter (P), coding region (CD) and just prior to the transcription termination site (3′), of four constitutively expressed genes, PMA1, PGK1, YEF3 and
ADH1 was examined by qPCR. Results were quantitated (see Materials and Methods), and Rpb1 binding in rpb4 cells is plotted relative to that in wt
cells (set equal to 1). (B) Rpb1 occupancy expressed as a ratio of 3′-end/Promoter levels, indicating an enrichment near the termination site on three of
four genes analyzed. (C) Rpb1-CTD Ser5P occupancy in wt and rpb4 strains analyzed by ChIP as in (A). (D) Rpb1-CTD Ser5P/Rpb1 ratios based on
data in (A) and (C). (E) Rpb1-CTD Ser2P occupancy in wt and rpb4 strains analyzed by ChIP as in (A). (F) Rpb1-CTD Ser2P/Rpb1 ratios based on
data in (A) and (E).
with strongly reduced Rpb1 ChIP signals at promoters and
throughout the rest of the gene as observed in rpb4Δ cells
(Figure 2A). These mutants may also have defects in elon-
gation, termination and/or pre-mRNA processing due to
RNAPII hyperphosphorylation (Figure 1A–C). In fact, it
has been shown that Rpb4 contributes to cotranscriptional
recruitment of 3′-end processing factors (8).
Next, we investigated the phosphorylation status of the
CTD of RNAPII bound to chromatin. Chromatin was pu-
rified from rpb4, rpb7-ΔC3 and rpb6-Q100Rmutant cells,
and the levels of Rpb4, Rpb1, Ser2P, Ser5P and Ser7P were
measured by western analysis (Figure 1E). As a control,
we included the rpb5-H174R mutant, which has no effect
on CTD phosphorylation (unpublished data). The results
show that in chromatin fractions from rpb4, rpb6-Q100R
and rpb7-Δ33 strains, in which Rpb4 levels are absent or re-
duced, the levels of Ser2P, Ser5P and Ser7P were increased
(Figure 1E, upper and bottom left panels). The increased
CTD phosphorylation cannot be explained solely by in-
creased chromatin-bound Rpb1, as indicated by the ratios
of CTD phosphorylation versus Rpb1 (Figure 1E, right
graph). These data suggest that chromatin-bound RNAPII
requires a functional Rpb4/7 heterodimer to be appropri-
ately phosphorylated.
To analyze the effects of RPB4 deletion on RNAPII oc-
cupancy and CTD modification along individual constitu-
tively transcribed genes, we used ChIP (Figure 2). Two an-
tibodies were used for Rpb1, Y80, which recognizes the
N-terminal domain (Figure 2A, left panel), and 8WG16
(Supplementary Figure S2B), which recognizes mostly un-
phosphorylated CTD but whose epitope may be masked
by Ser2 phosphorylation. In fact, under conditions where
Ser2P levels are increased, an artificial decrease in Rpb1 has
been observed using 8WG16 (50,61). Using ChIP probes in
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Figure 3. Ssu72 is functionally dependent on Rpb4. (A) Genetic interaction between RPB4 and SSU72. Serial dilutions (1:10) of wt and mutant strains
were spotted on rich medium and grown for 2–3 days at the indicated temperatures. RPB4 deletion exacerbates ssu72–2 slow growth at 28oC and 33oC,
while overexpression of SSU72 partially suppresses the slow growth phenotype of rpb4 strain. Growth was on SCmedia for 2–3 days. (B) Overexpression
of RPB4 or RPB4/RPB7 (coexpression), but not RPB7, suppress the thermosensitivity of the ssu72–2 strain. The corresponding strains (wt and ssu72–2)
were transformed with empty vectors or with high-copy plasmids bearing RPB4 and/or RPB7 and grown on SC media for 2–3 days at 28oC, 33oC and
37oC. (C) Overexpression of SSU72 reduces Ser5P levels in rpb4 mutant cells. Reductions are also detected for Ser2P and Ser7P (see text). Western
blot analysis was performed using WCE from wt and rpb4 cells transformed with an empty vector or a high-copy plasmid bearing SSU72 and grown
to mid-logarithmic phase in SC. Graph on the right represents the mean values of Ser2P/Rpb1, Ser5P/Rpb1 and Ser7P/Rpb1 ratios from at least three
independent experiments. Error bars are standard deviations from the mean. (D) ChIP analysis of Ssu72-MYC chromosomally integrated in wt and rpb4
cells. ChIPwas performed using anti-MYCantibodies. Ssu72-MYC crosslinking to the promoter and 3′-end regions ofADH1,PGK1,PMA1 andYEF3was
analyzed by qPCR and occupancy in the rpb4 mutant was normalized to that in wt cells. The graph show mean values of three independent experiments,
and error bars represent standard deviations. Middle panel, Ssu72/Rpb1 ratios are graphed and show that similar levels of Ssu72 and Rpb1 are recruited
to promoter and 3′-end regions. Right panel, Ssu72/Ser5P ratios are depicted, and indicate a decrease of Ssu72 in promoter and 3′ regions relative to the
CTD-Ser5P substrate. (E) Western analysis of CTD phosphorylation levels on chromatin fractions of wt and rpb4 cells expressing Ssu72-MYC. Histone
H3 and Pgk1 are included as controls as in Figure 1E. Right panel, ratios of Ssu72 to Rpb1, Ser2P, Ser5P and Ser7P indicate a depletion of Ssu72 in
chromatin relative to multiple RNAPII forms. (F) Co-IP performed onWCEs from Ssu72-MYC cells (wt and rpb4) using an anti-Rpb3 antibody. Inputs
and IPs were analyzed by western blotting with antibodies to the indicated proteins. Right panel, mean values from the quantification of immunoreactive
signals from three experiments, where error bars represent standard deviations.
the promoter, coding region, and 3′-end of PMA1, PGK1,
YEF3 andADH1 (Supplementary Figure S2A)we observed
a significant reduction in Rpb1 occupancy (using Y80) in
all three regions in rpb4 cells (Figure 2A). Similar re-
sults were obtained using the 8WG16 antibody, despite
the presumed increase in Ser2P levels, and an antibody
against another RNAPII subunit (Rpb3) (Supplementary
Figure S2B). Thus, in the absence of Rpb4, RNAPII occu-
pancy was reduced, even though total Rpb1 was increased
((8); Figure 1, this study). These findings suggest that im-
pairment of the Rpb4/7 heterodimer results in an excess
of RNAPII not engaged in productive transcription. The
ChIP data also revealed a more pronounced decrease in
Rpb1 occupancy at the promoters compared with the 3′-
ends of the genes examined (Figure 2B).
We also analyzed Ser5P and Ser2P levels in rpb4 mu-
tants using ChIP (Figure 2C–F). Surprisingly, while Ser5P
occupancy during transcription was reduced in rpb4 cells,
the relative levels of Ser5P versus Rpb1 (Ser5P/Rpb1)
clearly increased at the promoter regions of all the genes
tested. No major changes in the Ser5P/Rpb1 ratios in
coding and 3′-end regions were observed, with the excep-
tion of the ADH1 gene, where the Ser5P/Rpb1 ratio is
higher at the 3′-end in rpb4 versus wild-type cells. In the
case of Ser2P, only coding and 3′-end regions were an-
alyzed, because Ser2P is almost undetectable at promot-
ers (43,50). A significant enrichment of Ser2P at 3′-end re-
gions was observed, which become more evident by the
Ser2P/Rpb1 ratios (Figure 2E and F). Similar results were
obtained using 8WG16 antibodies to immunoprecipitate
Rpb1 and using anti-Rpb3 with the exception of theADH1
gene that shows a slightly different pattern (Supplemen-
tary Figure S3). Taken together, the results demonstrate
that the Rpb4/7 heterodimer is required to maintain nor-
mal RNAPII CTD phosphorylation levels. Below, we inves-
tigate potential mechanism(s) for how Rpb4/7 might func-
tion to regulate CTD phosphorylation.
Ssu72 is functionally dependent on Rpb4
Results thus far indicate that compromising Rpb4/7 func-
tion leads to abnormally high levels of Ser2P, Ser5P and
Ser7P. To investigate the possibility that high Ser5/7P levels
result from misregulation of Ssu72, a Ser5P (and Ser7P)-
specific phosphatase (61), we carried out genetic interac-
tion experiments. We used the temperature-sensitive ssu72–
2 mutant, which displays impaired phosphatase activity in
vitro, accumulation of Ser5P in vivo and defects in transcrip-
tion elongation (76,77). At permissive temperatures (28◦C,
33◦C), the rpb4 ssu72–2 double mutants grew slower than
either mutant alone (Figure 3A, upper panel). In contrast,
overexpression of SSU72 partially rescued growth of rpb4
at 33◦C (Figure 3A, lower panel), while overexpression of
RPB4 partially rescued growth of ssu72–2 at 37◦C (Figure
3B, upper panel). A stronger rescue of ssu72–2was observed
by co-overexpressing RPB4 and RPB7 (Figure 3B, lower
panel). In contrast, RPB7 alone had no effect (Figure 3B,
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Figure 4. Ess1 and Rpb4/7 are genetically linked. (A) Genetic interaction between RPB4 and ESS1. Serial dilutions of wt and mutant strains were spotted
on rich medium and grown for 2–3 days at the indicated temperatures. RPB4 deletion further slows growth of ess1-A144T and ess1-H164R strains. (B)
Overexpression of RPB4/7, partially suppresses the growth defect of the ess1-T144A strain at all temperatures tested, while it suppresses the ess1-H164R
strain detectably only at 37oC.Wild-type and ess1-T144A cells were transformed with the corresponding empty vectors or with high-copy plasmids bearing
RPB4 and/or RPB7 and grown on SC at the indicated temperatures. (C) Overexpression of ESS1 exacerbates the slow growth of rpb4 cells at 28oC and
33oC. Cells were grown on SC media for 2–3 days at the indicated temperatures. (D) Co-expression of RPB4/7 reduces Ser5P and Ser7P levels in ess1-
T144A mutant. Western blot analysis with the indicated antibodies were performed using WCE from wt and ess1-T144A cells transformed with empty
vectors or with RPB4 and RPB7 high-copy plasmids, and grown to mid-logarithmic phase at 28oC in SC. (E) ChIP analysis of Ess1-TAP chromosomally
integrated in wt and rpb4 cells. Mean values of the relative occupancy of Ess1 at 5′ and 3′ ends at the indicated genes are plotted, where wt values are
considered 1. Error bars represent standard deviations.
middle panel). These genetic data suggest that Rpb4/7 and
Ssu72 functions are closely related.
We next determined whether suppression of the rpb4
growth defect by SSU72 was accompanied by a reduc-
tion of CTD-Ser5P and CTD-Ser7P levels. Western anal-
ysis showed that overexpression of SSU72 reduced CTD-
Ser5P and Ser7 levels in rpb4 cells toward wild-type levels
(Figure 3C), consistent with the genetic data. Surprisingly,
SSU72 overexpression also reduced Ser2P levels.
Genome-wide studies show that Ssu72 is present primar-
ily at the 3′ ends of genes with some detectable at transcrip-
tion start sites (61,64). To determine whether Rpb4/7 is re-
quired for localization of Ssu72, we carried out ChIP us-
ing wild-type and rpb4 mutant cells (Figure 3D). Ssu72
association with promoter and 3′-end regions was signifi-
cantly reduced in rpb4 cells, when compared with Ser5P
CTD levels (Figure 3D). If instead, Ssu72 association in
rpb4 cells is compared with total Rpb1 levels, the differ-
ence is no longer apparent, clouding the issue of Rpb4-
dependent recruitment of Ssu72. To resolve this issue, we
carried out additional experiments. We found that Ssu72
levels are in fact decreased in bulk chromatin in rpb4 mu-
tants, even when compared to the levels of Rpb1, and com-
pared to Ser2P, Ser5P and Ser7P, which increased signifi-
cantly (Figure 3E). And, using Co-IP with Rpb3, we found
that Ssu72 interaction with RNAPII is decreased in rpb4
mutant (Figure 3F). These results are consistent with the
idea that increased CTD-Ser5P phosphorylation in rpb4
cells is a consequence of a defect in recruitment of the Ssu72
phosphatase to the RNAPII complex. These results do not,
however, rule out additional effects of Rpb4 on the access of
Ssu72 to the CTD substrate within chromatin or its activity.
Ess1 and Rpb4/7 are linked, likely via Ssu72
Similar to rpb4 mutant described above, mutations in the
ESS1 gene increase Ser5 and Ser7 phosphorylation lev-
els, while overexpression decreases Ser5P (Ser7P was not
tested) (63,68,78).Mechanistically, the Ess1 isomerase stim-
ulates Ssu72 phosphatase binding and catalytic activity
(69). In addition, overexpression of RPB7 from Candida al-
bicans suppresses ess1 mutants (34). Therefore, we tested
whether Rpb4/7 and Ess1 are functionally related. Indeed,
genetic interaction experiments showed that RPB4 dele-
tion enhanced the growth defect of two ts-mutants, ess1-
A144T and ess1-H164R, (34), whereas co-overexpression
of RPB4/7 (but not of either gene alone) suppressed the
growth defect (Figure 4A and B). Overexpression of ESS1,
which decreases Ser5P levels (78), did not rescue rpb4 cells
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and seemed to further reduce the growth of rpb4 cells (Fig-
ure 4C).
We next determined whether suppression of the growth
defect of ess1 mutant cells by overexpression of RPB4/7
was correlated with CTD-Ser5P and CTD-Ser7P levels,
which are known to be elevated in these mutants (63,68,78).
Indeed, western analysis revealed that overexpression of
RPB4/7 restored CTD-Ser5P and Ser7P levels in ess1-
A144T cells back down to wild-type levels (Figure 4D), con-
sistent with the observed genetic suppression.We noted that
in some experiments total Rpb1 levels were increased in ess1
mutants (data not shown), and this increase was reversed
by RPB4/7. Together, these data suggest that Rpb4/7 sup-
presses ess1 mutants by controlling overall levels of Rpb1
and its phosphorylation, particularly on CTD-Ser5 and
CTD-Ser7.
Finally, recruitment of Ess1 to the 5′ and 3′ ends of genes
was not significantly reduced in rpb4 cells (Figure 4E), rul-
ing out the simple explanation for the genetic interaction
results (failure to recruit Ess1). Together these data reveal
a functional interaction between Ess1 and Rpb4/7, most
likely via a common target, Ssu72, and suggest that coordi-
nation between isomerization and CTD phosphorylation is
important during the transcription cycle.
Rpb4 is required for proper Fcp1 association and Ser2P and
Thr4P dephosphorylation
Given that rpb4 cells have increased Ser2P levels and that
Fcp1 has been identified as the major Ser2P phosphatase,
we investigated whether Rpb4 promotes Fcp1 function.
Consistent with this idea, we found that by increasing FCP1
expression, the growth defects of rpb4 cells were par-
tially suppressed (Figure 5A, upper panel). In the recipro-
cal experiment RPB4 overexpression partially suppressed
the growth defects of fcp1–1 (Figure 5A, bottom panel),
which lacks phosphatase activity leading to increased Ser2P
levels (79,80). It has been shown that in mammalian cells,
MCF inactivation at mitosis exit requires Fcp1 (81). There-
fore, it is possible that in yeast Fcp1 has also other func-
tions in addition to its role in CTDdephosphorylation. This
may, in part, account for the inability of fcp1–1 growth de-
fects to be fully suppressed by RPB4 overexpression. As
expected, increased expression of FCP1 reduced the levels
of Ser2P phosphorylation in rpb4Δ cells back to wild-type
levels (Figure 5B). In contrast, Ser5P levels were affected
very little, indicating that Fcp1 retained its specificity (Fig-
ure 5B).
In mammals, Fcp1 was also shown to dephosphorylate
CTD-Thr4P (67). If Rpb4 is important for Fcp1 to de-
phosphorylate Thr4P, then Thr4P levels should increase in
rpb4mutant. Indeed, this is what we observed (Figure 5C,
left panel), and this effect seems to be mediated by Fcp1,
because Thr4P levels are specifically increased in the fcp1–1
mutant (as are Ser2P levels), but not in the ssu72–2 mutant
(Figure 5C). These results suggest that Rpb4 facilitates de-
phosphorylation of Thr4P and Ser2P by Fcp1.
Similar to results with Ssu72, the occupancy of Fcp1
as measured by ChIP (in coding and 3′ regions) in the
four query genes was strongly decreased in rpb4 cells,
especially when compared to levels of its substrate tar-
get modification, CTD-Ser2P (Figure 5D). However, sim-
ilar to the case with Ssu72, normalization to Rpb1 does
not reveal a large difference in occupancy of Fcp1, sup-
porting the alternative model (not mutually exclusive) that
Rpb4/7 might play a role subsequent to Fcp1 binding,
such as positioning of the phosphatase (providing access
to its substrate) or controlling its activity. Using a Myc-
tagged Fcp1 strain, we could Co-IP significant amounts of
Rpb4 using anti-Myc antibodies (Figure 5E). And, Fcp1
co-immunoprecipitated much more Ser2P in rpb4 cells
than in the wild type. Together, the results suggest that in
the absence of Rpb4/7, Fcp1 associates with RNAPII more
weakly, and that the Fcp1 that is bound is not able to effi-
ciently de-phosphorylate Ser2P. In summary, the results are
consistent with a positive role for Rpb4 on Fcp1 activity to-
ward the RNAII CTD.
Finally, we performedCo-IP assays to determine whether
the association of Fcp1 with RNAPII in vivo is Rpb4-
dependent. Less Fcp1 was associated with RNAPII in
rpb4 cells as detected by IP with an anti-Rpb3 antibody
(Figure 5F, left panel). This reduction is apparent when
comparing Fcp1 to levels of Rpb1 in rpb4 cells, and espe-
cially when comparing to levels of Ser2P-, Ser5P- and Ser7-
modified RNAPII (Figure 5F, right panel).
Effect of RPB4 deletion on Kin28 and Ctk1 functions
Our data thus far do not exclude the possibility that, in ad-
dition to the effects on CTD phosphatases, Rpb4 also influ-
ences the binding or activity of CTD kinases. For example,
it is possible that Kin28, Ctk1 and Srb10 kinases contribute
to the increased phosphorylation of Ser5, Ser2 and Ser7.
To investigate this possibility, we analyzed the genetic re-
lationships between RPB4 and KIN28, CTK1 and SRB10.
RPB4 was deleted from strains containing two kin28 alle-
les, kin28-T17D and kin28-T162A (carried on a plasmid),
or chromosomal ctk1Δ and srb10Δ mutations. The kin28-
T17D mutant has decreased CTD kinase activity, a defect
in capping enzyme recruitment and is slow growing at 25oC
and 37oC. The kin28-T162A allele, which does not display
a slow growth phenotype, has reduced activity in vitro, but
does not detectably affect CTD phosphorylation and cap-
ping enzymes recruitment in vivo (44,82,83).
A simple prediction would be that mutations in CTD ki-
nases in rpb4 cells might restore CTD phosphorylation
levels (which are elevated) and thus suppress rpb4 growth
defects. However, this was not the case with two of the
three kinases. Instead, combining rpb4with kin28 resulted
in synthetic lethality at the permissive temperature (kin28-
T17D; Figure 6A, left and middle panels) or enhancement
of the slow growth phenotypes at 28oC and 33oC (kin28-
T162A; Figure 6A, right panel). The rpb4 ctk1 double
mutant also showed synthetic growth defects (Figure 6B).
Only srb10, which is thought to play a negative role in
transcription (40), suppressed, at leastmildly, rpb4 growth
defects (Figure 6C). Thus, although there are genetic in-
teractions between rpb4 and genes encoding three CTD
kinases, the interpretation of these results is not straight-
forward. This might be because Rpb4/7 functions during
multiple steps in transcription/CTD modification and that
the CTD kinases may have other important substrates be-
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Figure 5. Rpb4 is required for proper Fcp1 association and Ser2 dephosphorylation. (A) Genetic interactions between RPB4 and FCP1. Expression of
FCP1 from a centromeric plasmid partially suppresses the slow growth of rpb4 cells at 33oC, while overexpression of RPB4 partially suppresses the
thermosensitivity of the fcp1–1 mutant strain. Growth was on SC media for 2–3 days. (B) Expression of FCP1 reduces Ser2P levels (but not Ser5P levels)
in rpb4 mutant cells. Western analysis was performed using WCE from wt and rpb4 cells transformed with an empty vector or a centromeric plasmid
bearing FCP1 and grown to mid-logarithmic phase in SC. (C) RPB4 deletion increases CTD-Thr4P levels. Western analysis of WCE from wt, rpb4,
fcp1–1 and ssu72–2 cells, using anti-Rpb1 (Y80), anti-Ser2P, anti-Thr4P (Novus biological), anti-Rpb4 and anti-Pgk1. (D) ChIP analysis using anti-MYC
antibodies of wt and rpb4 strains bearing chromosomally integrated Fcp1-MYC. Fcp1-MYC occupancy on coding and 3′-end regions of ADH1, PGK1,
PMA1 and YEF3 was analyzed in rpb4 mutant cells by qPCR and normalized to that in wt cells. Middle panel, Fcp1/Rpb1 ratios indicate that Fcp1
occupancy is similar to that of Rpb1. Right panel, Fcp1/Ser2P ratios indicate reduced Fcp1 at coding and 3′ regions relative to its CTD-Ser2P substrate
(Ser2P ChIP, data not shown). (E) Co-IP using WCE from Fcp1-MYC cells (wt and rpb4) and anti-MYC antibody. Inputs and IPs were analyzed by
western blot with antibodies to the indicated proteins. (F) Co-IP using WCE from Fcp1-MYC cells (wt and rpb4) and anti-Rpb3 antibody. Inputs and
IPs were analyzed by western blot with antibodies to the indicated proteins. Right panel, mean values from the quantification of immunoreactive signals
from three experiments, where error bars represent standard deviations.
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Figure 6. Effect of RPB4 deletion on Kin28 and Ctk1 functions. (A) Genetic interaction between RPB4 and KIN28. Left and middle panels: Growth of
RPB4 and rpb4 cells containing plasmid-borne copies of wild-type KIN28 (CEN, URA3) and either an empty vector (pTRP1) or kin28-T17D (CEN,
TRP1). Cells were streaked to SC media (left) or SC media containing 5-FOA (right) to select against the KIN28 plasmid. Combining the kin28-T17D
and rpb4 mutations results in synthetic lethality (kin28-T17D only supports growth in the RPB4+ background). Right panel, serial dilutions of wt and
mutant strains were spotted on SC medium and grown for 2–3 days at the indicated temperatures. RPB4 deletion in combination with kin28-T162V causes
a significant slow growth defect. (B and C) Genetic interaction between RPB4 and CTK1 and SRB10. Serial dilutions of wt and mutant strains were
spotted on rich medium and grown for 2–3 days at the indicated temperatures. Deletion of CTK1 exacerbates the slow growth of rpb4 at 28oC and 33oC,
while deletion of SRB10 partially rescues the slow growth of rpb4Δ. (D) ChIP analysis of Kin28-HA chromosomally integrated in wt and rpb4 cells.
ChIP was performed using anti-HA antibody. Kin28-HA crosslinking to promoter regions of ADH1, PGK1, PMA1 and YEF3 was analyzed by qPCR
and occupancy in the rpb4 mutant was normalized to that in wt cells, considered as 1. Kin28/Rpb1 ratios (Rpb1 ChIP data not shown) showed slightly
increased occupancy of Kin28 at promoters relative to Rpb1. (E) Ctk1-HA occupancy was carried out by ChIP and ratios were determined as in (D) above.
sides the CTD.Another possibility was suggested by further
analysis of rpb4 ctk1 double mutants, which showed
very low levels of Rpb1 (Supplementary Figure S4), per-
haps below a threshold required to sustain vigorous growth.
These data also indicate that elevated Ser2P levels in the
rpb4 mutant are dependent on Ctk1, because this mark
was nearly absent in the rpb4 ctk1 cells, compared with
Ser5P, which was present (Supplementary Figure S4).
To determine whether the effects on CTD phosphory-
lation by Rpb4/7 are predominantly through the CTD
phosphatases or CTD kinases, we examined recruitment of
Kin28 (to promoters), Ctk1 (to coding and 3′ regions) and
Srb10 (to UAS regions) of active genes using ChIP. Kin28
occupancy on promoters was reduced in rpb4 cells when
compared to wild-type cells (Figure 6D), consistent with
the genetic interaction. However, when normalized to the
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amount of Rpb1, the occupancy of Kin28 in rpb4 cells
was not significantly higher in three of the five genes tested
(Figure 6D, right panel). This suggests that the increase in
Ser5P and Ser7P in rpb4 cells is more likely the result of
failure to dephosphorylate these serines (by Ssu72) than an
‘over-recruitment’ of the corresponding kinase (Kin28).
In contrast, ChIP analysis of Ctk1 revealed a strong
increase in relative Ctk1 recruitment in rpb4 cells (Fig-
ure 6E). The increased occupancy of Ctk1/Rpb1 on cod-
ing and 3′ regions, in coordination with decrease in Fcp1
association and/or access may contribute to the observed
hyperphosphorylation of Ser2 in rpb4 cells. Furthermore,
the high Ser5P levels could lead to increased Ser2P because,
as previously shown, Ctk1 acts on the CTD already phos-
phorylated on Ser5P (84). Finally, ChIP analysis of Srb10
recruitment did not show significant changes in rpb4 cells
(data not shown).
In summary, our results show that Rpb4/7 heterodimer
modulates RNAPII phosphorylation, and that it likely
functions primarily by facilitating the association, recruit-
ment and/or accessibility of the CTD phosphatases, Ssu72
and Fcp1.
DISCUSSION
In this study, we showed that impairing Rpb4/7 het-
erodimer function by deleting Rpb4 or mutating Rpb7
subunits, or preventing its recruitment to RNAPII, cause
elevated CTD phosphorylation at Ser2, Ser5, Ser7 and
Thr4. Consistent with these changes in phosphorylation of
RNAPII, we found genetic interactions between RPB4 and
genes encoding the CTD phosphatases Ssu72 and Fcp1,
and the CTD kinases Kin28, Ctk1 and Srb10.We also show
genetic interactions between RPB4 and ESS1, which en-
codes a prolyl isomerase that targets the CTD and affects
its phosphorylation. Finally, using fractionation, ChIP and
Co-IP, we found that Rpb4 helps recruit both Fcp1 and
Ssu72 to RNAPII, and that association of these enzymes
with RNAPII and their access/activity toward their sub-
strates is decreased in rpb4 mutants, explaining, in large
part, the increased phosphorylation.
Our findings lead to the following model. Rpb4/7 is re-
cruited to the core RNAPII complex via Rpb6 (and Rpb1)
as previously shown (85,86). The Rpb6 subunit is conserved
in RNAPI and RNAPIII, and archaeal RNAP (K), and
might play an analogous role in recruiting the correspond-
ing stalk subunits. There is even an Rpb6 ortholog in bac-
teria () that plays a role in assembly of the other four core
RNAP subunits (87). Once recruited, the Rpb4/7 complex
is positioned near the RNA exit channel and the Rpb1-
CTD (14), where it likely carries out two sets of functions.
First are the CTD-independent functions shared with other
‘stalk-containing’ polymerases (RNAPI, RNAPIII and ar-
chaeal RNAP). These would potentially includeDNAmelt-
ing during initiation (88), stabilization of the elongation
complex by an RNA binding-dependent mechanism (lead-
ing to increased processivity) and contributions to site-
specific termination (2). The second set ofRpb4/7 functions
would be CTD-dependent functions, specific to RNAPII
and would include association, recruitment and/or acces-
sibility, of CTD-modifying enzymes and CTD-binding co-
factors required for RNA processing. Regulating levels of
CTD phosphorylation may not have been the primary role
of Rpb4/7. Instead, this activity could have been acquired
as the role of the CTD became integral for coupling of co-
transcriptional processes, and facilitated by the proximity of
theRpb4/7 heterodimer to theCTDaswell as theRNAexit
chanel (14). Here, we showed that Rpb4/7 helps recruit and
potentially position/activate the CTD phosphatases, Ssu72
and Fcp1, and may inhibit the binding of the CTD kinases
Kin28 and Ctk1. Thus, Rpb4/7 would promote an over-
all dephosphorylation of the CTD, and help keep Ser2P,
Ser5P, Ser7P and Thr4P levels in check. Recruitment of the
Rpb4/7 heterodimer to elongating RNAPII may itself be
regulated (9), so its effects on CTDphosphorylationmay be
more complex, and possibly gene-specific. Rpb4/7may also
impact RNAPII processivity and recycling efficiency by in-
creasing RNAPII occupancy via its effects on CTD phos-
phorylation levels. Consistent with this model, increased
CTD phosphorylation (on Ser2, Ser5, Ser7) relative to to-
tal Rpb1 was observed not only in rpb4Δ and rpb7 mu-
tants, but also in a rpb6 and a rpb1 missense mutants that
reduce Rpb4/7 recruitment to the RNAPII core (Figure 1
and (75,89). The increased Ser5P levels in rpb4 cells (Fig-
ure 2C and D) correlates well with the strongly decreased
recruitment of the Ser5P-specific phosphatase Ssu72 (Fig-
ure 3D), and to the slightly increased of the Ser5 kinase
Kin28 to promoters (Figure 6D). Likewise, the increased
Ser2P levels in coding and 3′ regions in rpb4 cells (Fig-
ure 2E and F) correlates well with the decreased recruitment
of the Ser2P-specific phosphatase Fcp1, particularly in 3′ re-
gions (Figure 5D), and to the increased Ser2 kinase Ctk1 in
these regions (Figure 6E). These findings are consistent with
earlier work showing that Rpb4 binds Fcp1 in S. pombe
and in Drosophila (20). The increases in Ser2P levels in the
rpb4Δ mutant (in which Fcp1 recruitment is compromised)
are Ctk1-dependent, as indicated by the fact that Ser2P lev-
els were dramatically reduced in rpb4ctk1  double mu-
tants (Supplementary Figure S4). Notably, Ser7P, which is
a target of Ssu72 is also significantly increased in rpb4,
rpb7 and rpb6 mutants (Figure 1), and Thr4P (Figure 5C),
which is a target of Fcp1 in human cells (67) is extraordinar-
ily enhanced in rpb4mutants, consistent with a conserved
function for Fcp1 as the Thr4P phosphatase from yeast to
mammals.
Our genetic evidence also supports the idea that recruit-
ment of CTD phosphatases is a major factor in governing
the Rpb4/7-dependent control of CTD phosphorylation.
For example, overexpression of either SSU72 or FCP1 sup-
pressed the slow growth of rpb4 cells (Figures 3A and 5A),
and restored (lowered) Ser5P/Ser7P and Ser2P levels, re-
spectively (Figures 3C and 5B). Note that overexpression
of SSU72, which should be Ser5/Ser7P-specific, also low-
ered Ser2P levels (Figure 3C), perhaps due to a reduced
substrate specificity when expressed at the higher concen-
trations, or from Ssu72 stimulating Fcp1 activity as pre-
viously observed (61). In addition, the synthetic-lethality
of rpb4 ess1ts mutants, and rescue of ess1ts mutants by
RPB4/7 overexpression are consistent with a defective re-
cruitment of CTD phosphatases in rpb4, as corroborated
by the fact that RPB4/7 overexpression reduces the high
levels of Ser5P and Ser7P in ess1mutant cells. Ess1 increases
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Ssu72 activity by isomerizing its substrate, Ser5P-Pro6 in
the CTD (69). Therefore, the combination of reduced re-
cruitment of Ssu72 (due to rpb4) and reduced activity
(due to ess1ts) predicts a more severe phenotype, as was ob-
served (Figure 4A), while increased Rpb4/7, which should
enhance Ssu72 recruitment, compensated for the ess1ts de-
fect (Figure 4B).
Genetic interactions with the CTD kinases (Figure 6)
were more difficult to interpret, and suggested that multiple
pathways were affected in double mutant cells. For exam-
ple, the synthetic lethality of rpb4 kin28 double mutants
was not predicted, because these mutations should have
opposite effects on CTD phosphorylation. However, both
Kin28 and Rpb4/7 have functions during transcription ini-
tiation (i.e. (41,90,91), that can be significantly impaired
when the two mutations are combined. In the rpb4ctk1
double mutants, the slow growth may have been caused by
the nearly undetectable levels of Rpb1, possibly due to pro-
tein degradation, becauseRPB1 transcription is not altered
(data not shown).
Finally, fractionation and Co-IP experiments strongly
support a phosphatase recruitment model. Both Ssu72 and
Fcp1 were associated with chromatin fractions and inter-
acted directly (or indirectly) with the RNAPII complex in a
manner that was dependent upon Rpb4 (Figures 3E and F
and 5C and E). And asmentioned above, ChIP data showed
that the access/activity of Ssu72 and Fcp1 may also be de-
pendent on Rpb4 (Figures 3D and 5D).
In agreement with published work (8), we found a signif-
icant increase in total cellular Rpb1 levels in rpb4 cells,
while at the same time a decrease in Rpb1 occupancy at the
3′ ends of genes (Figures 1 and 2A). In contrast, we also ob-
serve a reduction in Rpb1 occupancy at promoters in rpb4
cells, even when compared to 3′ occupancy (Figure 2A and
B). This difference might be due to increased sensitivity in
our ChIP assays. One interpretation of our results is that
in the absence of Rpb4, release of Rpb1 could be impaired
after termination, which would in turn reduce RNAPII re-
cycling, explaining the reduction of Rpb1 occupancy at the
promoter. This could be a consequence of the CTD dephos-
phorylation defect in rpb4 cells, similar to the reduced
Rpb1 crosslinking to promoters and increased Ser2P ob-
served in fcp1 mutants, which are proposed to have a re-
cycling defect (50,66). Finally, the aberrant CTD phospho-
rylation (higher Ser5P) and lower Ssu72 at termination re-
gions that we observed might also contribute to the known
termination defects in rpb4 mutants (8,64).
In summary, our results show that the Rpb4/7 het-
erodimer controls covalent modification of the RNAPII,
specifically, the phosphorylation of the Rpb1 CTD. The
most likely mechanism is by enhancing recruitment of
Ssu72 and Fcp1 phosphatases to the chromatin-bound
RNAPII and or positioning them allowing their access to
their substrate. Although the exact mechanism of recruit-
ment is not known, Rpb4/7 could exert effects directly on
theCTD,making itmore accessible to binding by Ssu72 and
Fcp1. Additionally, it could work indirectly through some
other polymerase-associated proteins, and/or by or exclud-
ing the CTD kinases. Finally, our data do not rule out the
possibility of ‘pre-binding’ of Rpb4/7 to Ssu72 and Fcp1
to facilitate their entry into the RNAPII complex. Further
work will be needed to dissect the mechanism of action of
Rpb4/7 on CTD phosphorylation, its regulation and how
Rpb4/7 effects CTD phosphorylation fit into the larger pic-
ture of ‘CTD code’ regulation.
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